Ideal candidates include those with BMI 30 (or 27 with comorbidities), stable cardiovascular history, normal kidney function, and no personal or family history of medullary thyroid cancer
The Bristol Stool Chart Doesnt Lie If your stool is usually: Type 1 or 2 constipated Type 3 with straining functionally constipated Type 4 without strain gold standard Frequency without form is meaningless
While liraglutide has proven effective for weight management, it is essential to note that it may not suit everyone
Glucagon-like peptide 1 analogs and their effects on pancreatic islets
Thanks to Kamika Reynolds, Kim O'Malley, and Jason Roy for their invaluable contributions, and to the National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for supporting this work